ChondroFiller®: A Regenerate-First Option for Cartilage Repair

What is ChondroFiller®?

ChondroFiller® is an injectable, acellular collagen scaffold designed to repair focal articular cartilage defects. Delivered as a liquid and gelling in minutes once placed, it fills the defect precisely and provides a 3-D framework that invites your own cells to migrate in, mature, and lay down hyaline-like cartilage. In short: it is a one-step structural regenerative implant, not a temporary lubricant or merely a pain-reliever.

How does it work?

• Fill & stabilise: The liquid collagen conforms to the unique shape of the defect and gels to form a stable matrix.
• Recruit & regenerate: The matrix attracts endogenous progenitor cells from the joint lining and subchondral bone, supporting their differentiation into cartilage-forming chondrocytes.
• Remodel: Over time the scaffold is resorbed and replaced by patient-derived, hyaline-like cartilage that integrates with surrounding tissue.

Key benefits

• Single-stage, minimally invasive: Often performed as a precise injection for small joints, or arthroscopically for larger or complex lesions.
• Structural repair: Provides a scaffold for true tissue regeneration rather than scar-tissue fill.
• Versatile: Used in knees, hips, shoulders, ankles, hands and small joints (including TMJ).
• Compelling outcomes: Studies report meaningful improvements in function and pain (for example, knee IKDC gains commonly around 30 points over 12–36 months) with consistently high MRI repair quality scores.
• Excellent safety profile: Widely used internationally with very low complication rates reported.

Who is a good candidate?

Adults with focal cartilage defects (typically up to several square centimetres) and otherwise stable joints often benefit most. It is suited to patients keen to preserve their native joint surface, including active individuals and those wishing to delay or avoid joint replacement. Suitability is confirmed with clinical assessment and MRI, and by addressing any contributing issues (for example, malalignment or meniscal/labral pathology) within a comprehensive plan.

What results can I expect?

While every patient and joint is different, published series across multiple joints show:

• Function: Sustained improvements on patient-reported outcome measures (e.g., IKDC for knees; mHHS for hips).
• Pain: Marked reductions on visual analogue or numerical scales.
• Imaging: High MOCART scores indicating substantial defect fill, good integration and surface quality.

Recovery milestones vary by joint and lesion size. Most protocols include protected loading for several weeks, progressive physiotherapy, and a graded return to sport and impact activities.

How does ChondroFiller® compare to other options?

Treatment pathways at MSK Doctors

Working within a regenerate-first philosophy, MSK Doctors offers three evidence-led routes, tailored after consultation and MRI:

1. Ultrasound-guided injections (small joints and selected larger joints): Clinic-based, no incisions; typically 1.0–2.3 ml depending on joint and defect.
2. Keyhole (arthroscopic) placement: Direct visual placement for larger or complex knee, hip, shoulder or ankle lesions; often combined with addressing co-pathology.
3. Liquid Cartilage™ (exclusive protocol): ChondroFiller® combined with patient-derived medicinal signalling cells (e.g., bone marrow, fat or PRF) for bigger or more challenging defects.

Indicative fees

• Clinic injections: typically £2,100–£2,800 depending on joint and volume.
• Arthroscopic placement: typically from £6,500 (knee) to £9,500 (hip/shoulder), reflecting complexity and hospital costs.
• Liquid Cartilage™: from around £3,800 for injection protocols; arthroscopic combinations from around £9,500.

Exact pricing depends on joint, defect size, imaging, and whether adjunctive procedures are required. Your consultation will include a personalised plan and a clear costed proposal.

Why Prof. Paul Lee and MSK Doctors?

• World-class expertise: Prof. Paul Lee is a Consultant Orthopaedic Surgeon and Honorary Professor of Sports Medicine with a track record in joint preservation and cartilage regeneration.
• Regeneration, not replacement: An outcomes-driven approach that prioritises repairing the joint before considering prosthetic options.
• Advanced diagnostics: Harley Street facilities with motion analysis, precise ultrasound guidance and MRI-led planning.
• Teaching excellence: Recognised centre for cartilage regeneration education and technique refinement.

Your journey

1. Discovery call: A brief, no-obligation conversation to understand your goals.
2. Consultation + MRI: Comprehensive assessment with Prof. Lee; discussion of options and expected outcomes.
3. Treatment day: Injection or keyhole placement as indicated; most patients go home the same day.
4. Rehabilitation & follow-up: Structured physiotherapy and milestones, with imaging when appropriate.

FAQs

Is ChondroFiller® suitable if I already have arthritis?
It is designed for focal defects in otherwise salvageable joints. In early degenerative change, results can still be favourable if co-pathology is addressed; advanced “bone-on-bone” arthritis is less suited.

How long until I feel better?
Pain and function often improve over weeks to months, with tissue maturation continuing over the first year. Timelines vary by joint, defect size and rehabilitation.

Will I definitely avoid a joint replacement?
No treatment can guarantee that, but preserving and regenerating cartilage early can delay or reduce the need for arthroplasty in many patients.

Summary

ChondroFiller® offers a modern, one-step path to structural cartilage repair, combining minimal invasiveness with compelling clinical outcomes. Under the guidance of Prof. Paul Lee at MSK Doctors, patients receive a tailored, regeneration-first plan that aims to protect, repair and restore joint function.

Take the next step

Ready to explore whether ChondroFiller® is right for you? Book a discovery call or arrange a consultation with Prof. Paul Lee at MSK Doctors to get a personalised assessment and treatment plan.